Evaluating the drug use "gateway" theory using cross-national data: consistency and associations of the order of initiation of drug use among participants in the WHO World Mental Health Surveys
- PMID: 20060657
- PMCID: PMC2835832
- DOI: 10.1016/j.drugalcdep.2009.12.001
Evaluating the drug use "gateway" theory using cross-national data: consistency and associations of the order of initiation of drug use among participants in the WHO World Mental Health Surveys
Abstract
Background: It is unclear whether the normative sequence of drug use initiation, beginning with tobacco and alcohol, progressing to cannabis and then other illicit drugs, is due to causal effects of specific earlier drug use promoting progression, or to influences of other variables such as drug availability and attitudes. One way to investigate this is to see whether risk of later drug use in the sequence, conditional on use of drugs earlier in the sequence, changes according to time-space variation in use prevalence. We compared patterns and order of initiation of alcohol, tobacco, cannabis, and other illicit drug use across 17 countries with a wide range of drug use prevalence.
Method: Analyses used data from World Health Organization (WHO) World Mental Health (WMH) Surveys, a series of parallel community epidemiological surveys using the same instruments and field procedures carried out in 17 countries throughout the world.
Results: Initiation of "gateway" substances (i.e. alcohol, tobacco and cannabis) was differentially associated with subsequent onset of other illicit drug use based on background prevalence of gateway substance use. Cross-country differences in substance use prevalence also corresponded to differences in the likelihood of individuals reporting a non-normative sequence of substance initiation.
Conclusion: These results suggest the "gateway" pattern at least partially reflects unmeasured common causes rather than causal effects of specific drugs on subsequent use of others. This implies that successful efforts to prevent use of specific "gateway" drugs may not in themselves lead to major reductions in the use of later drugs.
Keywords: WHO World Mental Health Surveys; alcohol; gateway; illicit drugs; tobacco.
Copyright 2009 Elsevier Ireland Ltd. All rights reserved.
References
-
- Alonso J, Ferrer M, Romera B, Vilagut G, Angermeyer M, Bernert S, Brugha TS, Taub N, McColgen Z, de Girolamo G, Polidori G, Mazzi F, De Graaf R, Vollebergh WA, Buist-Bowman MA, Demyttenaere K, Gasquet I, Haro JM, Palacin C, Autonell J, Katz SJ, Kessler RC, Kovess V, Lépine JP, Arbabzadeh-Bouchez S, Ormel J, Bruffaerts R. The European Study of the Epidemiology of Mental Disorders (ESEMeD/MHEDEA 2000) project: rationale and methods. Int. J. Methods Psychiatr. Res. 2002;11:55–67. - PMC - PubMed
-
- American Psychiatric Association [APA] Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association; Washington DC: 1994.
-
- Angrist J, Krueger A. Instrumental variables and the search for identification: From supply and demand to natural experiments. Journal of Economic Perspectives. 2001;15(4):69–85.
-
- Breslau NN, Scott P, Kessler RC. Psychiatric disorders and stages of smoking. Biol. Psychiatry. 2004;55:69–76. - PubMed
-
- Degenhardt L, Chiu W-T, Sampson N, Kessler R, Anthony J, Angermeyer M, Bruffaerts R, de Girolamo G, Gureje O, Huang Y, Karam A, Kostyuchenko S, Lepine J-P, Mora M.-E. Medina, Neumark Y, Ormel J, Pinto-Meza A, Posada-Villa J, Stein D, Takeshima T, Wells E. Toward a global view of alcohol, tobacco, cannabis and cocaine use: Findings from the WHO World Mental Health Surveys. PLoS Medicine. 2008;5:e141. doi:10.1371/journal.pmed.0050141. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
- R03 TW006481/TW/FIC NIH HHS/United States
- DA010075/DA/NIDA NIH HHS/United States
- K05 DA015799/DA/NIDA NIH HHS/United States
- R13-MH066849/MH/NIMH NIH HHS/United States
- DA15454/DA/NIDA NIH HHS/United States
- R01-TW006481/TW/FIC NIH HHS/United States
- R13 MH066849/MH/NIMH NIH HHS/United States
- R01-MH059575/MH/NIMH NIH HHS/United States
- R01 DA016558/DA/NIDA NIH HHS/United States
- U01-MH60220/MH/NIMH NIH HHS/United States
- R01-MH61905/MH/NIMH NIH HHS/United States
- R01MH070884/MH/NIMH NIH HHS/United States
- R01 MH061905/MH/NIMH NIH HHS/United States
- R01-MH069864/MH/NIMH NIH HHS/United States
- K01 DA015454/DA/NIDA NIH HHS/United States
- U01 MH060220/MH/NIMH NIH HHS/United States
- R01 MH070884/MH/NIMH NIH HHS/United States
- R21 DA024260/DA/NIDA NIH HHS/United States
- R01 MH059575/MH/NIMH NIH HHS/United States
- U13 MH066849/MH/NIMH NIH HHS/United States
- T32 DA021129/DA/NIDA NIH HHS/United States
- DA024260/DA/NIDA NIH HHS/United States
